Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Press Releases

Bone Therapeutics to regain worldwide rights to ALLOB

  • Read more about Bone Therapeutics to regain worldwide rights to ALLOB

Bone Therapeutics to host Extraordinary General Meeting on 24 October 2022

  • Read more about Bone Therapeutics to host Extraordinary General Meeting on 24 October 2022

Bone Therapeutics: Information on the total number of voting rights and shares

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares

Transparency notification received from CPH Banque

  • Read more about Transparency notification received from CPH Banque

Bone Therapeutics: Information on the total number of voting rights and shares (December 2020)

  • Read more about Bone Therapeutics: Information on the total number of voting rights and shares (December 2020)

Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study

  • Read more about Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study

Bone Therapeutics announces pricing of private placement

  • Read more about Bone Therapeutics announces pricing of private placement

Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent

  • Read more about Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent

Bone Therapeutics, Cerhum, 3D-Side, mSKIL and IREC awarded €3M in BioWin supported funding to develop personalized, tissue engineered bone implants

  • Read more about Bone Therapeutics, Cerhum, 3D-Side, mSKIL and IREC awarded €3M in BioWin supported funding to develop personalized, tissue engineered bone implants

Bone Therapeutics Provides Third Quarter 2020 Business Update

  • Read more about Bone Therapeutics Provides Third Quarter 2020 Business Update

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Press Releases
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions